期刊文献+

灵芝三萜防治口腔黏膜癌及其对细胞的作用 被引量:3

Prevention of Triterpenoids Isolated from Ganoderma Lucidum on Oral Carcinoma and Its Effects on Cells
暂未订购
导出
摘要 目的:探讨灵芝三萜在口腔癌变发生发展过程中的抑制作用和机制。方法:建立金黄地鼠颊囊动态癌变的动物模型,采用免疫组化技术检测caspase-3在两组动物模型中的表达变化,并进行统计学处理。结果:在整个癌变动态观察期内,两组颊囊癌变过程中不同组织学发生情况有显著差异(P<0.01),A组病变严重程度始终低于B组。随着上皮病变程度的加剧,caspase-3的表达呈现逐步增强趋势。A组与B组相比,在正常组、上皮单纯增生组、上皮异常增生组、鳞癌的不同病损中,A组阳性率低于B组。A组与B组正常组和上皮单纯增生组相比差异均无显著性。但在上皮异常增生和鳞癌组织中A组与B组差异均有显著性(P<0.05)。结论:灵芝三萜对口腔黏膜癌发展过程中具有抑制作用并可能不是通过细胞凋亡途径发挥作用,而可能发挥直接细胞毒作用。 Objective: To discuss the inhibition mechanism of ganoderma triterpenoids in the development and progression of oral cancer. Methods: We established two hamster cheek pouch dynamic cancer animal models and examined the expression of caspase -3 by immunohistochemistry technology. The data was analyzed with jmtjrj 10.34. Results: In the whole dynamic carcinogenesis observation period, the occurrence of two groups'histological difference was significant (P 〈 0.01 ). The severity in group A was always lower than that in group B. Immunohistoehemical study of caspase - 3 showed that its expression gradually strengthened with the development of epithelial lesions. In different lesions from normal, simple hyperplasia, dyspiasia to carcinoma, the positive stainings of group A were slightly lower than those of group B. There was no significant difference in the normal and simple hyperplasia between group A and B by rank sum test. However, there was a significant difference in dysplasia and carcinoma between group A and B(P 〈 0.05). Conclusion: Ganoderma triterpenoids can inhibit carcinoma of the oral mucosa. Ganoderma triterpenes might not play a role in apoptosis, conversely, it might exhibit directly a cytotoxic effect.
出处 《口腔医学研究》 CAS CSCD 2008年第5期487-490,共4页 Journal of Oral Science Research
基金 吉林省科技厅资助课题(编号:20050405-1)
关键词 灵芝三萜 口腔鳞癌 CASPASE-3 抗肿瘤 Ganoderma triterpenoids OSCC Caspase - 3 Antitumor
  • 相关文献

参考文献10

二级参考文献74

  • 1杨桂芳,邓长生,熊永炎,罗峻,汪必成,田素芳,徐柯.核因子κB p65及靶基因在CagAHp胃癌及癌前病变中的表达研究[J].中华肿瘤杂志,2004,26(9):551-553. 被引量:7
  • 2吴颜晖,陈汉春,刘新发,李新梅,曹燕飞.中国人食管鳞癌10q23微卫星不稳定和杂合性缺失初步探讨[J].中国肿瘤临床,2004,31(8):466-468. 被引量:9
  • 3[1]LaCasse EC, Baird S, Korneluk RG, et al. The inhibitors of apoptosis(IAPs) and their emerging role in cancer [J].Oncogene, 1998, 17 (25): 3247 - 3259.
  • 4[2]Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor ofcaspase-3 and-7 [J].Biochemistry, 2001, 40(4): 1117 - 1123.
  • 5[3]Cohen C, Lohmann CM, Cotsonis G, et al. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis [J]. Mod Pathol, 2003, 16(6):574-583.
  • 6[4]Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95),Bax, caspases, and anticancer drugs [J] . Cancer Res, 1998,58(23): 5315 -5320.
  • 7[5]Wang CY, Mayo MW, Korneluk RG, et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation [J]. Science, 1998, 281(5383): 1680 - 1683.
  • 8[6]Suzuki A, Ito T, Kawano H, et al. survivininitiates procaspase-3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death [J]. Oncogene,2000, 19 (10): 1346 - 1353.
  • 9[7]Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma [J]. Nat Med,1997, 3(8): 917 -921.
  • 10[8]Kanavaros P, Bai M, Stefanaki K, et al. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67,cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas [J]. Histol Histopathol, 2001, 16(2): 377 -386.

共引文献64

同被引文献33

  • 1时衍同,刘伟,潘丽.非小细胞肺癌Bcl-2蛋白表达及其与细胞凋亡和增殖的关系[J].山东医药,2005,45(16):31-32. 被引量:2
  • 2侯晓青,程桂芝.灰树花多糖抗荷瘤小鼠S180肉瘤的实验研究[J].中国药房,2007,18(3):180-181. 被引量:13
  • 3孙玮,高飞,张利宁.新的抑癌基因PDCD4最新研究进展[J].药物分析杂志,2007,27(7):1138-1141. 被引量:7
  • 4Wargovich M J, Woods C, Hollis D M, et al. Herbals cancer prevention and health [ J ]. J Nutr,2001,131 ( 11 ) : 3034.
  • 5Seikea M, Gotoa A, Okanoa T, et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers [ J ]. PNAS, 2009, 106 (29) : 12085.
  • 6Asangani I A, Rasheed S A K, Nikolova D A, et al. MicroRNA- 21 (miR-21) post*transcriptionally downregulates tumor suppressor Paled4 and stimulates invasion, intravasation and metastasis in colorectal cancer[J]. Oncogene, 2008(27) : 2128.
  • 7Zhang J G, Wang J J , Zhao F, et al. MicroRNA-21 ( miR-21 ) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC) [J]. Clin Chimica Acta, 2010,411:846.
  • 8Cmarik J, Min H, Hegamyer G, et al. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation[ J]. Proc Natl Acad Sci USA, 1999, 96: 14037.
  • 9Jan sen A P,amalier C E,Stark C,et al. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity [ J ]. Mol Cancer Ther, 2004,3 (2) : 103.
  • 10WARGOVICH M J,WOODS C,HOLLIS D M,et al.Her-bals,cancer prevention and health[J].J Nutr,2001,131(11):S3034-S3036.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部